Page last updated: 2024-11-07

2,2-dimethyl-beta-alanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,2-Dimethyl-beta-alanine, also known as DMBA, is a branched-chain amino acid that has gained attention for its potential as a dietary supplement. It is a structural analog of beta-alanine, a naturally occurring amino acid involved in the synthesis of carnosine and anserine, which act as buffers against muscle fatigue. DMBA is not directly incorporated into proteins, but it shares similarities with beta-alanine in its metabolic pathways and potential physiological effects. Research suggests that DMBA may possess similar muscle-building and performance-enhancing properties as beta-alanine, although the mechanisms of action and precise effects are still under investigation. Studies have explored the potential of DMBA to increase muscle mass, strength, and endurance, as well as its potential for enhancing athletic performance and recovery. However, there is limited clinical data on the safety and effectiveness of DMBA supplements, and more research is needed to establish its long-term effects and optimal dosage. The compound's unique structure and potential for impacting muscle metabolism have made it a subject of ongoing research in sports science, nutrition, and biochemistry.'

Cross-References

ID SourceID
PubMed CID95739
CHEMBL ID2074956
SCHEMBL ID434731
MeSH IDM0060289

Synonyms (34)

Synonym
nsc32047
nsc-32047
19036-43-2
3-amino-2,2-dimethylpropanoicacid
3-amino-2,2-dimethylpropanoic acid
3-amino-2,2-dimethyl-propanoic acid
propanoic acid, 3-amino-2,2-dimethyl-
unii-gn6q6n22nj
2-methylaminoisobutyric acid
2,2-dimethyl-beta-alanine
nsc 32047
gn6q6n22nj ,
CHEMBL2074956
FT-0648461
AKOS011494777
amino-2,2-dimethylpropanoic acid
3-amino-2,2-dimethyl-propionic acid
DGNHGRLDBKAPEH-UHFFFAOYSA-N
SCHEMBL434731
AB49662
DTXSID20172516
J-511522
2-methyl-aminoisobutyric acid
CS-0107300
mfcd09055365
3-amino-2,2-dimethylpropionic acid
.beta.-aminopivalic acid
2,2-dimethyl-.beta.-alanine
aminopivalic acid
.beta.-alanine, 2,2-dimethyl-
D76726
BS-52234
A853250
EN300-67276
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID681113TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes2001The Journal of biological chemistry, May-18, Volume: 276, Issue:20
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (146)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.37)18.7374
1990's65 (44.52)18.2507
2000's61 (41.78)29.6817
2010's16 (10.96)24.3611
2020's2 (1.37)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index5.05 (2.92)
Research Growth Index6.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (2.65%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.66%)4.05%
Observational0 (0.00%)0.25%
Other146 (96.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]